Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.

CONCLUSION: Statins can prevent the proliferative HCB effects on Hep-G2 cells. TGF-β1, c-Src and TH may be the statins molecular targets in hepatocarcinogenesis. PMID: 29735800 [PubMed - in process]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research